APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clinical Trials Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Clinical Trials Outsourcing Market Outlook and Growth Opportunities 2026

4 January 2026219 pages

Choose your research edition.

Industry ResearchClinical Trials Outsourcing Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Trials Outsourcing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Clinical Trials Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Trials Outsourcing Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Trials Outsourcing Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Clinical Trials Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Clinical Trials Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Clinical Trials Outsourcing market include Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Clinical Trials Outsourcing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Clinical Trials Outsourcing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Clinical Trials Outsourcing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Clinical Trials Outsourcing market.

Clinical Trials Outsourcing Segment by Company

Charles River Laboratories

IQVIA

ICON PLC

Labcorp Drug Development

Syneos Health

Thermo Fisher Scientific

Wuxi AppTec

Parexel

Advanced Clinical

BioAnalytix

Curia Global

CMED

Cromos Pharma

Criterium

KCR S.A.

Medpace

Medelis

OCT Group

ProTrials Research

PROMETRIKA

Quality Data Service

QPS

Sofpromed

Veristat

Worldwide Clinical Trials

Clinical Trials Outsourcing Segment by Type

Phase I

Phase II

Phase III

Phase IV

Clinical Trials Outsourcing Segment by Application

Cancer

CVDs

Infectious Diseases

Musculoskeletal Diseases

Nervous System Disorders

Others

Clinical Trials Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Clinical Trials Outsourcing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Clinical Trials Outsourcing key companies, revenue, market share, and recent developments.

3. To split the Clinical Trials Outsourcing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Clinical Trials Outsourcing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Clinical Trials Outsourcing significant trends, drivers, influence factors in global and regions.

6. To analyze Clinical Trials Outsourcing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trials Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trials Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trials Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trials Outsourcing industry.

Chapter 3: Detailed analysis of Clinical Trials Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Clinical Trials Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Clinical Trials Outsourcing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Clinical Trials Outsourcing Industry Trends Table 2. Clinical Trials Outsourcing Industry Drivers Table 3. Clinical Trials Outsourcing Industry Opportunities and Challenges Table 4. Clinical Trials Outsourcing Industry Restraints Table 5. Global Clinical Trials Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Clinical Trials Outsourcing Revenue Share by Company (2021-2026) Table 7. Global Clinical Trials Outsourcing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Clinical Trials Outsourcing Key Company Manufacturing Base & Headquarters Table 9. Global Clinical Trials Outsourcing Company, Product Type & Application Table 10. Global Clinical Trials Outsourcing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Clinical Trials Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Phase I Table 15. Significant Companies of Phase II Table 16. Significant Companies of Phase III Table 17. Significant Companies of Phase IV Table 18. Global Clinical Trials Outsourcing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Clinical Trials Outsourcing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Clinical Trials Outsourcing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Clinical Trials Outsourcing Sales Value Share by Type (2021-2026) Table 22. Global Clinical Trials Outsourcing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Cancer Table 24. Significant Companies of CVDs Table 25. Significant Companies of Infectious Diseases Table 26. Significant Companies of Musculoskeletal Diseases Table 27. Significant Companies of Nervous System Disorders Table 28. Significant Companies of Others Table 29. Global Clinical Trials Outsourcing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Clinical Trials Outsourcing Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Clinical Trials Outsourcing Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Clinical Trials Outsourcing Sales Value Share by Application (2021-2026) Table 33. Global Clinical Trials Outsourcing Sales Value Share by Application (2027-2032) Table 34. Global Clinical Trials Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Clinical Trials Outsourcing Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Clinical Trials Outsourcing Sales Value Share by Region (2021-2026) Table 37. Global Clinical Trials Outsourcing Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Clinical Trials Outsourcing Sales Value Share by Region (2027-2032) Table 39. Global Clinical Trials Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Clinical Trials Outsourcing Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Clinical Trials Outsourcing Sales Value Market Share by Country (2021-2026) Table 42. Global Clinical Trials Outsourcing Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Clinical Trials Outsourcing Sales Value Market Share by Country (2027-2032) Table 44. Charles River Laboratories Company Information Table 45. Charles River Laboratories Business Overview Table 46. Charles River Laboratories Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Charles River Laboratories Clinical Trials Outsourcing Product Portfolio Table 48. Charles River Laboratories Recent Development Table 49. IQVIA Company Information Table 50. IQVIA Business Overview Table 51. IQVIA Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. IQVIA Clinical Trials Outsourcing Product Portfolio Table 53. IQVIA Recent Development Table 54. ICON PLC Company Information Table 55. ICON PLC Business Overview Table 56. ICON PLC Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ICON PLC Clinical Trials Outsourcing Product Portfolio Table 58. ICON PLC Recent Development Table 59. Labcorp Drug Development Company Information Table 60. Labcorp Drug Development Business Overview Table 61. Labcorp Drug Development Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio Table 63. Labcorp Drug Development Recent Development Table 64. Syneos Health Company Information Table 65. Syneos Health Business Overview Table 66. Syneos Health Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Syneos Health Clinical Trials Outsourcing Product Portfolio Table 68. Syneos Health Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. Wuxi AppTec Company Information Table 75. Wuxi AppTec Business Overview Table 76. Wuxi AppTec Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Wuxi AppTec Clinical Trials Outsourcing Product Portfolio Table 78. Wuxi AppTec Recent Development Table 79. Parexel Company Information Table 80. Parexel Business Overview Table 81. Parexel Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Parexel Clinical Trials Outsourcing Product Portfolio Table 83. Parexel Recent Development Table 84. Advanced Clinical Company Information Table 85. Advanced Clinical Business Overview Table 86. Advanced Clinical Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Advanced Clinical Clinical Trials Outsourcing Product Portfolio Table 88. Advanced Clinical Recent Development Table 89. BioAnalytix Company Information Table 90. BioAnalytix Business Overview Table 91. BioAnalytix Clinical Trials Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. BioAnalytix Clinical Trials Outsourcing Product Portfolio Table 93. BioAnalytix Recent Development Table 94. Curia Global Company Information Table 95. Curia Global Business Overview Table 96. Curia Global Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Curia Global Clinical Trials Outsourcing Product Portfolio Table 98. Curia Global Recent Development Table 99. CMED Company Information Table 100. CMED Business Overview Table 101. CMED Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. CMED Clinical Trials Outsourcing Product Portfolio Table 103. CMED Recent Development Table 104. Cromos Pharma Company Information Table 105. Cromos Pharma Business Overview Table 106. Cromos Pharma Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Cromos Pharma Clinical Trials Outsourcing Product Portfolio Table 108. Cromos Pharma Recent Development Table 109. Criterium Company Information Table 110. Criterium Business Overview Table 111. Criterium Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Criterium Clinical Trials Outsourcing Product Portfolio Table 113. Criterium Recent Development Table 114. KCR S.A. Company Information Table 115. KCR S.A. Business Overview Table 116. KCR S.A. Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. KCR S.A. Clinical Trials Outsourcing Product Portfolio Table 118. KCR S.A. Recent Development Table 119. Medpace Company Information Table 120. Medpace Business Overview Table 121. Medpace Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Medpace Clinical Trials Outsourcing Product Portfolio Table 123. Medpace Recent Development Table 124. Medelis Company Information Table 125. Medelis Business Overview Table 126. Medelis Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Medelis Clinical Trials Outsourcing Product Portfolio Table 128. Medelis Recent Development Table 129. OCT Group Company Information Table 130. OCT Group Business Overview Table 131. OCT Group Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. OCT Group Clinical Trials Outsourcing Product Portfolio Table 133. OCT Group Recent Development Table 134. ProTrials Research Company Information Table 135. ProTrials Research Business Overview Table 136. ProTrials Research Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. ProTrials Research Clinical Trials Outsourcing Product Portfolio Table 138. ProTrials Research Recent Development Table 139. PROMETRIKA Company Information Table 140. PROMETRIKA Business Overview Table 141. PROMETRIKA Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. PROMETRIKA Clinical Trials Outsourcing Product Portfolio Table 143. PROMETRIKA Recent Development Table 144. Quality Data Service Company Information Table 145. Quality Data Service Business Overview Table 146. Quality Data Service Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Quality Data Service Clinical Trials Outsourcing Product Portfolio Table 148. Quality Data Service Recent Development Table 149. QPS Company Information Table 150. QPS Business Overview Table 151. QPS Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. QPS Clinical Trials Outsourcing Product Portfolio Table 153. QPS Recent Development Table 154. Sofpromed Company Information Table 155. Sofpromed Business Overview Table 156. Sofpromed Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Sofpromed Clinical Trials Outsourcing Product Portfolio Table 158. Sofpromed Recent Development Table 159. Veristat Company Information Table 160. Veristat Business Overview Table 161. Veristat Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Veristat Clinical Trials Outsourcing Product Portfolio Table 163. Veristat Recent Development Table 164. Worldwide Clinical Trials Company Information Table 165. Worldwide Clinical Trials Business Overview Table 166. Worldwide Clinical Trials Clinical Trials Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio Table 168. Worldwide Clinical Trials Recent Development Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Clinical Trials Outsourcing Product Image Figure 2. Global Clinical Trials Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Trials Outsourcing Market Size (2021-2032) & (US$ Million) Figure 4. Global Clinical Trials Outsourcing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Phase I Image Figure 8. Phase II Image Figure 9. Phase III Image Figure 10. Phase IV Image Figure 11. Global Clinical Trials Outsourcing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Clinical Trials Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Clinical Trials Outsourcing Sales Value Share by Type (2021-2032) Figure 14. Cancer Image Figure 15. CVDs Image Figure 16. Infectious Diseases Image Figure 17. Musculoskeletal Diseases Image Figure 18. Nervous System Disorders Image Figure 19. Others Image Figure 20. Global Clinical Trials Outsourcing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Clinical Trials Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Clinical Trials Outsourcing Sales Value Share by Application (2021-2032) Figure 23. Global Clinical Trials Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Clinical Trials Outsourcing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Clinical Trials Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 26. North America Clinical Trials Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Clinical Trials Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Clinical Trials Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Clinical Trials Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Clinical Trials Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Clinical Trials Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 32. South America Clinical Trials Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Clinical Trials Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Clinical Trials Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Applications
  • Cancer
  • CVDs
  • Infectious Diseases
  • Musculoskeletal Diseases
  • Nervous System Disorders
  • Others
Companies covered
  • Charles River Laboratories
  • IQVIA
  • ICON PLC
  • Labcorp Drug Development
  • Syneos Health
  • Thermo Fisher Scientific
  • Wuxi AppTec
  • Parexel
  • Advanced Clinical
  • BioAnalytix
  • Curia Global
  • CMED
  • Cromos Pharma
  • Criterium
  • KCR S.A.
  • Medpace
  • Medelis
  • OCT Group
  • ProTrials Research
  • PROMETRIKA
  • Quality Data Service
  • QPS
  • Sofpromed
  • Veristat
  • Worldwide Clinical Trials

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Clinical Trials Outsourcing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Clinical Trials Outsourcing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Clinical Trials Outsourcing Market Dynamics
  1. 2.1 Clinical Trials Outsourcing Industry Trends
  2. 2.2 Clinical Trials Outsourcing Industry Drivers
  3. 2.3 Clinical Trials Outsourcing Industry Opportunities and Challenges
  4. 2.4 Clinical Trials Outsourcing Industry Restraints
3 Clinical Trials Outsourcing Market by Company
  1. 3.1 Global Clinical Trials Outsourcing Company Revenue Ranking in 2025
  2. 3.2 Global Clinical Trials Outsourcing Revenue by Company (2021-2026)
  3. 3.3 Global Clinical Trials Outsourcing Company Ranking (2024-2026)
  4. 3.4 Global Clinical Trials Outsourcing Company Manufacturing Base and Headquarters
  5. 3.5 Global Clinical Trials Outsourcing Company Product Type and Application
  6. 3.6 Global Clinical Trials Outsourcing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Clinical Trials Outsourcing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Clinical Trials Outsourcing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Clinical Trials Outsourcing Market by Type
  1. 4.1 Clinical Trials Outsourcing Type Introduction
  2. 4.1.1 Phase I
  3. 4.1.2 Phase II
  4. 4.1.3 Phase III
  5. 4.1.4 Phase IV
  6. 4.2 Global Clinical Trials Outsourcing Sales Value by Type
  7. 4.2.1 Global Clinical Trials Outsourcing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Clinical Trials Outsourcing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Clinical Trials Outsourcing Sales Value Share by Type (2021-2032)
5 Clinical Trials Outsourcing Market by Application
  1. 5.1 Clinical Trials Outsourcing Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 CVDs
  4. 5.1.3 Infectious Diseases
  5. 5.1.4 Musculoskeletal Diseases
  6. 5.1.5 Nervous System Disorders
  7. 5.1.6 Others
  8. 5.2 Global Clinical Trials Outsourcing Sales Value by Application
  9. 5.2.1 Global Clinical Trials Outsourcing Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Clinical Trials Outsourcing Sales Value by Application (2021-2032)
  11. 5.2.3 Global Clinical Trials Outsourcing Sales Value Share by Application (2021-2032)
6 Clinical Trials Outsourcing Regional Value Analysis
  1. 6.1 Global Clinical Trials Outsourcing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Clinical Trials Outsourcing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Clinical Trials Outsourcing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Clinical Trials Outsourcing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Clinical Trials Outsourcing Sales Value (2021-2032)
  7. 6.3.2 North America Clinical Trials Outsourcing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Clinical Trials Outsourcing Sales Value (2021-2032)
  10. 6.4.2 Europe Clinical Trials Outsourcing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Clinical Trials Outsourcing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Clinical Trials Outsourcing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Clinical Trials Outsourcing Sales Value (2021-2032)
  16. 6.6.2 South America Clinical Trials Outsourcing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Clinical Trials Outsourcing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Clinical Trials Outsourcing Sales Value Share by Country, 2025 VS 2032
7 Clinical Trials Outsourcing Country-level Value Analysis
  1. 7.1 Global Clinical Trials Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Clinical Trials Outsourcing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Clinical Trials Outsourcing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Clinical Trials Outsourcing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Clinical Trials Outsourcing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Clinical Trials Outsourcing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Clinical Trials Outsourcing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River Laboratories
  2. 8.1.1 Charles River Laboratories Company Information
  3. 8.1.2 Charles River Laboratories Business Overview
  4. 8.1.3 Charles River Laboratories Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Laboratories Clinical Trials Outsourcing Product Portfolio
  6. 8.1.5 Charles River Laboratories Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA Clinical Trials Outsourcing Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 ICON PLC
  14. 8.3.1 ICON PLC Company Information
  15. 8.3.2 ICON PLC Business Overview
  16. 8.3.3 ICON PLC Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ICON PLC Clinical Trials Outsourcing Product Portfolio
  18. 8.3.5 ICON PLC Recent Developments
  19. 8.4 Labcorp Drug Development
  20. 8.4.1 Labcorp Drug Development Company Information
  21. 8.4.2 Labcorp Drug Development Business Overview
  22. 8.4.3 Labcorp Drug Development Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio
  24. 8.4.5 Labcorp Drug Development Recent Developments
  25. 8.5 Syneos Health
  26. 8.5.1 Syneos Health Company Information
  27. 8.5.2 Syneos Health Business Overview
  28. 8.5.3 Syneos Health Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Syneos Health Clinical Trials Outsourcing Product Portfolio
  30. 8.5.5 Syneos Health Recent Developments
  31. 8.6 Thermo Fisher Scientific
  32. 8.6.1 Thermo Fisher Scientific Company Information
  33. 8.6.2 Thermo Fisher Scientific Business Overview
  34. 8.6.3 Thermo Fisher Scientific Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio
  36. 8.6.5 Thermo Fisher Scientific Recent Developments
  37. 8.7 Wuxi AppTec
  38. 8.7.1 Wuxi AppTec Company Information
  39. 8.7.2 Wuxi AppTec Business Overview
  40. 8.7.3 Wuxi AppTec Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wuxi AppTec Clinical Trials Outsourcing Product Portfolio
  42. 8.7.5 Wuxi AppTec Recent Developments
  43. 8.8 Parexel
  44. 8.8.1 Parexel Company Information
  45. 8.8.2 Parexel Business Overview
  46. 8.8.3 Parexel Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Parexel Clinical Trials Outsourcing Product Portfolio
  48. 8.8.5 Parexel Recent Developments
  49. 8.9 Advanced Clinical
  50. 8.9.1 Advanced Clinical Company Information
  51. 8.9.2 Advanced Clinical Business Overview
  52. 8.9.3 Advanced Clinical Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Advanced Clinical Clinical Trials Outsourcing Product Portfolio
  54. 8.9.5 Advanced Clinical Recent Developments
  55. 8.10 BioAnalytix
  56. 8.10.1 BioAnalytix Company Information
  57. 8.10.2 BioAnalytix Business Overview
  58. 8.10.3 BioAnalytix Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BioAnalytix Clinical Trials Outsourcing Product Portfolio
  60. 8.10.5 BioAnalytix Recent Developments
  61. 8.11 Curia Global
  62. 8.11.1 Curia Global Company Information
  63. 8.11.2 Curia Global Business Overview
  64. 8.11.3 Curia Global Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Curia Global Clinical Trials Outsourcing Product Portfolio
  66. 8.11.5 Curia Global Recent Developments
  67. 8.12 CMED
  68. 8.12.1 CMED Company Information
  69. 8.12.2 CMED Business Overview
  70. 8.12.3 CMED Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CMED Clinical Trials Outsourcing Product Portfolio
  72. 8.12.5 CMED Recent Developments
  73. 8.13 Cromos Pharma
  74. 8.13.1 Cromos Pharma Company Information
  75. 8.13.2 Cromos Pharma Business Overview
  76. 8.13.3 Cromos Pharma Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cromos Pharma Clinical Trials Outsourcing Product Portfolio
  78. 8.13.5 Cromos Pharma Recent Developments
  79. 8.14 Criterium
  80. 8.14.1 Criterium Company Information
  81. 8.14.2 Criterium Business Overview
  82. 8.14.3 Criterium Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Criterium Clinical Trials Outsourcing Product Portfolio
  84. 8.14.5 Criterium Recent Developments
  85. 8.15 KCR S.A.
  86. 8.15.1 KCR S.A. Company Information
  87. 8.15.2 KCR S.A. Business Overview
  88. 8.15.3 KCR S.A. Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 KCR S.A. Clinical Trials Outsourcing Product Portfolio
  90. 8.15.5 KCR S.A. Recent Developments
  91. 8.16 Medpace
  92. 8.16.1 Medpace Company Information
  93. 8.16.2 Medpace Business Overview
  94. 8.16.3 Medpace Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Medpace Clinical Trials Outsourcing Product Portfolio
  96. 8.16.5 Medpace Recent Developments
  97. 8.17 Medelis
  98. 8.17.1 Medelis Company Information
  99. 8.17.2 Medelis Business Overview
  100. 8.17.3 Medelis Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Medelis Clinical Trials Outsourcing Product Portfolio
  102. 8.17.5 Medelis Recent Developments
  103. 8.18 OCT Group
  104. 8.18.1 OCT Group Company Information
  105. 8.18.2 OCT Group Business Overview
  106. 8.18.3 OCT Group Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 OCT Group Clinical Trials Outsourcing Product Portfolio
  108. 8.18.5 OCT Group Recent Developments
  109. 8.19 ProTrials Research
  110. 8.19.1 ProTrials Research Company Information
  111. 8.19.2 ProTrials Research Business Overview
  112. 8.19.3 ProTrials Research Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ProTrials Research Clinical Trials Outsourcing Product Portfolio
  114. 8.19.5 ProTrials Research Recent Developments
  115. 8.20 PROMETRIKA
  116. 8.20.1 PROMETRIKA Company Information
  117. 8.20.2 PROMETRIKA Business Overview
  118. 8.20.3 PROMETRIKA Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 PROMETRIKA Clinical Trials Outsourcing Product Portfolio
  120. 8.20.5 PROMETRIKA Recent Developments
  121. 8.21 Quality Data Service
  122. 8.21.1 Quality Data Service Company Information
  123. 8.21.2 Quality Data Service Business Overview
  124. 8.21.3 Quality Data Service Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Quality Data Service Clinical Trials Outsourcing Product Portfolio
  126. 8.21.5 Quality Data Service Recent Developments
  127. 8.22 QPS
  128. 8.22.1 QPS Company Information
  129. 8.22.2 QPS Business Overview
  130. 8.22.3 QPS Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 QPS Clinical Trials Outsourcing Product Portfolio
  132. 8.22.5 QPS Recent Developments
  133. 8.23 Sofpromed
  134. 8.23.1 Sofpromed Company Information
  135. 8.23.2 Sofpromed Business Overview
  136. 8.23.3 Sofpromed Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Sofpromed Clinical Trials Outsourcing Product Portfolio
  138. 8.23.5 Sofpromed Recent Developments
  139. 8.24 Veristat
  140. 8.24.1 Veristat Company Information
  141. 8.24.2 Veristat Business Overview
  142. 8.24.3 Veristat Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Veristat Clinical Trials Outsourcing Product Portfolio
  144. 8.24.5 Veristat Recent Developments
  145. 8.25 Worldwide Clinical Trials
  146. 8.25.1 Worldwide Clinical Trials Company Information
  147. 8.25.2 Worldwide Clinical Trials Business Overview
  148. 8.25.3 Worldwide Clinical Trials Clinical Trials Outsourcing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio
  150. 8.25.5 Worldwide Clinical Trials Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst